Name | (3aS,4R,9bR)-4-(6-Bromo-1,3-benzodioxol-5-yl)-8-isopropyl-3a,4,5, 9b-tetrahydro-3H-cyclopenta[c]quinoline |
---|---|
Synonyms |
CaCCinh-A01
(3aS,4R,9bR)-4-(6-Bromo-1,3-benzodioxol-5-yl)-8-isopropyl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline 3H-Cyclopenta[c]quinoline, 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-8-(1-methylethyl)-, (3aS,4R,9bR)- G-36 |
Description | G-36 is a cell permeable non-steroidal antagonist of G-protein-coupled estrogen receptor (GPER/GPR30) which selectively inhibits estrogen-mediated activation of PI3K by GPER, but not by ERα. G-36 also inhibits estrogen-mediated calcium mobilization (IC50=112 nM)[1]. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 478.4±45.0 °C at 760 mmHg |
Molecular Formula | C22H22BrNO2 |
Molecular Weight | 412.320 |
Flash Point | 243.1±28.7 °C |
Exact Mass | 411.083374 |
PSA | 30.49000 |
LogP | 5.83 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.619 |